The Use of Dynamic Tracer Concentration in Veins for Quantitative DCE-MRI Kinetic Analysis in Head and Neck

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Yuan, Jing ^a   Chow, Steven Kwok Keung ^a   Zhang, Qinwei ^a   Yeung, David Ka Wai ^a   Ahuja, Anil T ^a   King, Ann D ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

GADOTERATE MEGLUMINE;

ADULT; ARTERY BLOOD FLOW; ARTICLE; AUTOMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; VEIN BLOOD FLOW;

EID: 84875129061     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059885     Document Type: Article

References (35)

1. Padhani AR, (2002) Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 16: 407-422.
2. Zahra MA, Hollingsworth KG, Sala E, Lomas DJ, Tan LT, (2007) Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol 8: 63-74.
3. O'Connor JP, Jackson A, Parker GJ, Roberts C, Jayson GC, (2012) Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies. Nat Rev Clin Oncol 9: 167-177.
4. Hoskin PJ, Saunders MI, Goodchild K, Powell ME, Taylor NJ, et al. (1999) Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer. Br J Radiol 72: 1093-1098.
5. Sumi M, Nakamura T, (2011) Extranodal spread in the neck: MRI detection on the basis of pixel-based time-signal intensity curve analysis. J Magn Reson Imaging 33: 830-838.
6. Shukla-Dave A, Lee NY, Jansen JF, Thaler HT, Stambuk HE, et al. (2012) Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases. Int J Radiat Oncol Biol Phys 82: 1837-1844.
7. Noworolski SM, Fischbein NJ, Kaplan MJ, Lu Y, Nelson SJ, et al. (2003) Challenges in dynamic contrast-enhanced MRI imaging of cervical lymph nodes to detect metastatic disease. J Magn Reson Imaging 17: 455-462.
8. Donaldson SB, Betts G, Bonington SC, Homer JJ, Slevin NJ, et al. (2011) Perfusion estimated with rapid dynamic contrast-enhanced magnetic resonance imaging correlates inversely with vascular endothelial growth factor expression and pimonidazole staining in head-and-neck cancer: a pilot study. Int J Radiat Oncol Biol Phys 81: 1176-1183.
9. Kim S, Loevner LA, Quon H, Kilger A, Sherman E, et al. (2010) Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol 31: 262-268.
10. Bisdas S, Seitz O, Middendorp M, Chambron-Pinho N, Bisdas T, et al. (2010) An exploratory pilot study into the association between microcirculatory parameters derived by MRI-based pharmacokinetic analysis and glucose utilization estimated by PET-CT imaging in head and neck cancer. Eur Radiol 20: 2358-2366.
11. Brix G, Semmler W, Port R, Schad LR, Layer G, et al. (1991) Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 15: 621-628.
12. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, et al. (1999) Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10: 223-232.
13. Buckley DL, (2002) Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn Reson Med 47: 601-606.
14. Di Giovanni P, Azlan CA, Ahearn TS, Semple SI, Gilbert FJ, et al. (2010) The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T. Phys Med Biol. 55: 121-132.
15. Evelhoch JL, (1999) Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 10: 254-259.
16. Cheng HL, (2007) T1 measurement of flowing blood and arterial input function determination for quantitative 3D T1-weighted DCE-MRI. J Magn Reson Imaging 25: 1073-1078.
17. Roberts C, Little R, Watson Y, Zhao S, Buckley DL, et al. (2011) The effect of blood inflow and B1-field inhomogeneity on measurement of the arterial input function in axial 3D spoiled gradient echo dynamic contrast-enhanced MRI. Magn Reson Med 65: 108-119.
18. Hansen AE, Pedersen H, Rostrup E, Larsson HB, (2009) Partial volume effect (PVE) on the arterial input function (AIF) in T1-weighted perfusion imaging and limitations of the multiplicative rescaling approach. Magn Reson Med 62: 1055-1059.
19. Foottit C, Cron GO, Hogan MJ, Nguyen TB, Cameron I, (2010) Determination of the venous output function from MR signal phase: feasibility for quantitative DCE-MRI in human brain. Magn Reson Med 63: 772-781.
20. Lavini C, Verhoeff JJ, (2010) Reproducibility of the gadolinium concentration measurements and of the fitting parameters of the vascular input function in the superior sagittal sinus in a patient population. Magn Reson Imaging 28: 1420-1430.
21. Ivancevic MK, Zimine I, Montet X, Hyacinthe JN, Lazeyras F, et al. (2003) Inflow effect correction in fast gradient-echo perfusion imaging. Magn Reson Med 50: 885-891.
22. Peeters F, Annet L, Hermoye L, Van Beers BE, (2004) Inflow correction of hepatic perfusion measurements using T1-weighted, fast gradient-echo, contrast-enhanced MRI. Magn Reson Med 51: 710-717.
23. Qin Q, Strouse JJ, van Zijl PC, (2011) Fast measurement of blood T1 in the human jugular vein at 3 Tesla. Magn Reson Med 65: 1297-1304.
24. Holdsworth DW, Norley CJ, Frayne R, Steinman DA, Rutt BK, (1999) Characterization of common carotid artery blood-flow waveforms in normal human subjects. Physiol Meas 20: 219-240.
25. Parker GJ, Roberts C, Macdonald A, Buonaccorsi GA, Cheung S, et al. (2006) Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med 56: 993-1000.
26. Schabel MC, Morrell GR, (2009) Uncertainty in T1 mapping using the variable flip angle method with two flip angles. Phys Med Biol 54: N1-8.
27. Yuan J, Chow SK, Yeung DK, Ahuja AT, King AD, (2012) Quantitative evaluation of dual-flip-angle T1 mapping on DCE-MRI kinetic parameter estimation in head and neck. Quant Imaging Med Surg 2: 245-253.
28. Leach MO, Morgan B, Tofts PS, Buckley DL, Huang W, et al. (2012) Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging. Eur Radiol 22: 1451-1464.
29. Heywang-Kobrunner SH, Haustein J, Pohl C, Beck R, Lommatzsch B, et al. (1994) Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine. Radiology 191: 639-646.
30. Brookes JA, Redpath TW, Gilbert FJ, Needham G, Murray AD, (1996) Measurement of spin-lattice relaxation times with FLASH for dynamic MRI of the breast. Br J Radiol 69: 206-214.
31. Yuan J, Chow SK, Yeung DK, King AD, (2012) A five-colour colour-coded mapping method for DCE-MRI analysis of head and neck tumours. Clin Radiol 67: 216-223.
32. Yuan J, Chow SK, King AD, Yeung DK, (2012) Heuristic linear mapping of physiological parameters in dynamic contrast-enhanced MRI without T1 measurement and contrast agent concentration. J Magn Reson Imaging 35: 916-925.
33. Rijpkema M, Kaanders JH, Joosten FB, van der Kogel AJ, Heerschap A, (2001) Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors. J Magn Reson Imaging 14: 457-463.
34. Tofts PS, (1997) Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 7: 91-101.
35. Noeske R, Seifert F, Rhein KH, Rinneberg H, (2000) Human cardiac imaging at 3 T using phased array coils. Magn Reson Med 44: 978-982.